Cite
HARVARD Citation
Carter, J. et al. (2017). Cost-effectiveness of subdermal implantable buprenorphine versus sublingual buprenorphine to treat opioid use disorder. Journal of medical economics. pp. 893-901. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Carter, J. et al. (2017). Cost-effectiveness of subdermal implantable buprenorphine versus sublingual buprenorphine to treat opioid use disorder. Journal of medical economics. pp. 893-901. [Online].